Imatinib and Dexamethasone Injection: Interaction Details
AI-assisted, pharmacist-reviewed · Source data updated Aug 8, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Imatinib
Dexamethasone Injection
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
What happens
Reduced imatinib exposure
Interaction Deep Dive
Avoid concomitant use of imatinib and dexAMETHasone (strong CYP3A4 inducer), as coadministration may reduce imatinib exposure. Consider alternative agents with less enzyme induction potential for patients receiving concomitant imatinib; however, if coadministration is required, increase imatinib dosage by at least 50% and carefully monitor clinical response1.
Why it happens (mechanism)
Induction of CYP3A4-mediated metabolism of imatinib
Literature reports
3 reports — tap to read
a) An 80-year-old man with chronic myeloid leukemia experienced an inadequate response to imatinib due to concurrent use of phenytoin (strong CYP3A4 inducer). His medications included phenytoin, bronchodilators and triptorelin. Imatinib was initiated at 400 mg/day resulting in a quick initial hematologic response. However, 3 months later there was a decrease in molecular response and the imatinib dose was increased to 600 mg resulting in a plasma trough level of 458 nanograms (ng/mL), which was still below the level for optimal response (greater than 1000 to 1165 ng/mL). Phenytoin was maintained for the entire duration of therapy without changes in dosage. Imatinib was increased further to 800 mg and plasma trough levels were increased to 699 ng/mL but lower than the anticipated median of 2690 ng/mL. The dose was reduced to 600 mg due to cytopenias, and 1 year later to 400 mg without any deterioration on the molecular response. Eight years after imatinib initiation, he is currently receiving imatinib 400 mg and is still in deep molecular response 2.
b) In a systematic review of studies of pharmacokinetic interactions involving St John's Wort, concomitant use with imatinib in 2 studies (N=12; N=10) resulted in a decrease in imatinib AUC of 30% and 32% with St John's Wort products containing hyperforin dosage of 15 mg/day 3.
c) In a drug interaction study in healthy volunteers receiving multiple doses of the strong CYP3A4 inducer rifAMPin followed by a single dose of oral imatinib, imatinib clearance increased by 3.8-fold, which significantly decreased mean Cmax and AUC 41.
Common questions
Can I take Imatinib and Dexamethasone Injection together?
Reduced imatinib exposure Always confirm with your pharmacist or prescriber before making any change.
How serious is the Imatinib and Dexamethasone Injection interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Imatinib or Dexamethasone Injection need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (4)
- Product Information: IMKELDI oral solution, imatinib oral solution. Shorla Oncology Inc. (per FDA), Cambridge, MA, 2024. DailyMed
- Osorio S, Escudero-Vilaplana V, Gomez-Centurion I, et al: Inadequate response to imatinib treatment in chronic myeloid leukemia due to a drug interaction with phenytoin. J Oncol Pharm Pract 2019; 25(3):694-698. PubMed
- Chrubasik-Hausmann S, Vlachojannis J, & McLachlan AJ: Understanding drug interactions with St John's wort (Hypericum perforatum L.): impact of hyperforin content. J Pharm Pharmacol 2019; 71(1):129-138.
- Product Information: GLEEVEC(R) oral tablets, imatinib mesylate oral tablets. Novartis Pharmaceuticals Corporation (per FDA), East Hanover, NJ, 2016. DailyMed
Keep reading about Imatinib
Keep reading about Dexamethasone Injection
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist